< Back to situations

[ORGANIZATION]

U.S. Department of Veterans Affairs

Featured in 19 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [AU] [GB]

Advancements in Alzheimer's blood tests and drug safety

13 clusters · 64 sources · last updated

Latest: FDA approves blood tests to assist in Alzheimer's diagnosis

Research into Alzheimer's biomarkers continues to evolve, with recent findings refining the utility of blood-based testing. While plasma p-tau217 remains a key indicator, studies suggest its predictive power in symptom-f

[QUIET] [POLITICS] [US]

US VA veteran homelessness assistance programs

2 clusters · 2 sources · last updated

Latest: U.S. Department of Veterans Affairs targets homelessness for justice-involved Veterans

The U.S. Department of Veterans Affairs (VA) has expanded its efforts to combat veteran homelessness through new legislative authorities and targeted outreach. In late July 2026, the VA implemented new authority under S

[QUIET] [HEALTH] [US]

US Department of Veterans Affairs EHR rollout

2 clusters · 2 sources · last updated

Latest: U.S. Department of Veterans Affairs begins nationwide health record rollout in Indiana

The U.S. Department of Veterans Affairs is advancing healthcare through medical research and the implementation of a new Federal Electronic Health Record (EHR) system. Initial efforts included using the National Veterans

[QUIET] [HEALTH] [US]

Mental health and suicide among US veterans

2 clusters · 2 sources · last updated

Latest: Mental health challenges and suicide rates impact US veterans

U.S. military veterans are facing significant mental health challenges, specifically regarding Post-Traumatic Stress Disorder (PTSD) and suicide rates. A study published in JAMA Network Open indicates that suicidal thoug

[QUIET] [HEALTH] [US] [MX] [GB]

US VA expands psychedelic trials for veteran PTSD

7 clusters · 21 sources · last updated

Latest: Heroic Hearts Project uses psychedelics to treat veteran PTSD

Mid‑July reports highlighted the absence of new pharmacologic PTSD options in the U.S., prompting clinics such as AtBrainHealth Solutions in Costa Mesa to adopt the five‑day, high‑dose SAINT TMS protocol. With no approve

Also covered in